Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Merge Healthcare Inc gives FY 2014 guidance; revenue and EBITDA guidance below analysts' estimates


Thursday, 20 Feb 2014 07:32am EST 

Merge Healthcare Inc:Expects FY 2014 sales in between $212 - $ 225 mln.Adjusted EBITDA in between $40 - $45 mln.Adjusted net income in between $16- $20 mln.Diluted net income per share in between $ 0.01 - $ 0.05.Diluted adjusted net income per share in between $ 0.16 - $ 0.21.FY 2014 revenue of $240 mln, EBITDA of $49 mln, net income of $18 mln and EPS of $0.19 - Thomson Reuters I/B/E/S. 

Company Quote

3.26
-0.02 -0.61%
21 Nov 2014